Family Practice News Digital Network Organized in a colorful graphic, the algorithm indicates drug preference in the familiar stepwise manner, beginning with the lowest-risk drugs – metformin and acarbose – for prediabetes, moving on to combinations and drugs with a higher side effect ... and more »
7thSpace Interactive (press release) We therefore examined the effects of a 24-week treatment of acarbose on endogenous GLP-1, nitric oxide (NO) levels, nitric oxide synthase (NOS) activity, and carotid intima-media thickness (CIMT) in newly diagnosed patients with type 2 diabetes (T2D).
Family Practice News Digital Network Organized in a colorful graphic, the algorithm indicates drug preference in the familiar stepwise manner, beginning with the lowest-risk drugs – metformin and acarbose – for prediabetes, moving on to combinations and drugs with a higher side effect ... and more »
7thSpace Interactive (press release) We therefore examined the effects of a 24-week treatment of acarbose on endogenous GLP-1, nitric oxide (NO) levels, nitric oxide synthase (NOS) activity, and carotid intima-media thickness (CIMT) in newly diagnosed patients with type 2 diabetes (T2D).
Family Practice News Digital Network Organized in a colorful graphic, the algorithm indicates drug preference in the familiar stepwise manner, beginning with the lowest-risk drugs – metformin and acarbose – for prediabetes, moving on to combinations and drugs with a higher side effect ... and more »
7thSpace Interactive (press release) We therefore examined the effects of a 24-week treatment of acarbose on endogenous GLP-1, nitric oxide (NO) levels, nitric oxide synthase (NOS) activity, and carotid intima-media thickness (CIMT) in newly diagnosed patients with type 2 diabetes (T2D).
